Gajanand International Ltd News

Indira IVF's $408 million India IPO may see EQT, founders exit stake

The company, backed by private equity firm EQT AB, plans to submit the so-called draft red herring prospectus later this month

Anthem Biosciences IPO Day 2 update: Fully subscribed, GMP hits 20%

Anthem Biosciences Day 2 subscription status: The non-institutional investors (NIIs) subscribed about 1.55 times the quota reserved for them

Office space company WeWork India gets regulatory approval for IPO

Offer for sale of 43.7 mn shares; proceeds go to Embassy Buildcon and 1 Ariel Way Tenant Ltd

MFs trim blue-chip stocks, cash reserves to capitalise on block deals

Fund managers acquired shares worth ₹10,500 crore in Asian Paints, with SBI MF and ICICI Prudential MF leading the purchase of a nearly 5 per cent stake sold by Reliance Industries

NRIs hold back on market bets amid tax knots and regulatory hurdles

Non-residents have tax deducted at source in India, along with potential taxation in their home countries

'Capital market-related stocks already discount couple of years of growth'

The margin of safety in capital market stocks for near-term investors is limited

HCLTech sees rating downgrade post Q1 results, guidance disappointment

Guidance indicates that margins will remain subdued in Q2FY26, as some restructuring cost will spill over

Sun Pharma gains on US launch of Leqselvi, analysts see strong upside

Sun Pharma rises 2.7% as it launches Leqselvi in US following settlement with Incyte, with analysts projecting $200-300 million revenue from the drug in 3-5 years

Board of Geojit Financial Services allots 96,667 equity shares under ESOS

AIFs must lead ESG push in unlisted firms, says Sebi's Ruchi Chojer

Sebi executive director says AIFs must align with global ESG norms as 40 per cent of capital comes from foreign investors expecting high disclosure standards